Oscar Health, Inc. (NYSE:OSCR) EVP Alessandrea C. Quane Sells 16,793 Shares

Oscar Health, Inc. (NYSE:OSCR) EVP Alessandrea C. Quane sold 16,793 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $17.06, for a total transaction of $286,488.58. Following the completion of the transaction, the executive vice president now directly owns 392,607 shares in the company, valued at approximately $6,697,875.42. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

Oscar Health Trading Up 2.8 %

Shares of OSCR stock opened at $17.47 on Tuesday. The business has a 50-day moving average of $17.01 and a 200 day moving average of $17.24. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.91 and a quick ratio of 0.91. Oscar Health, Inc. has a 1-year low of $4.72 and a 1-year high of $23.44. The stock has a market capitalization of $4.23 billion, a PE ratio of -43.67, a P/E/G ratio of 33.66 and a beta of 1.61.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.04. The firm had revenue of $2.20 billion during the quarter, compared to analyst estimates of $2.13 billion. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The business’s quarterly revenue was up 44.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.07) earnings per share. As a group, sell-side analysts anticipate that Oscar Health, Inc. will post 0.01 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. Bank of America reiterated a “neutral” rating and issued a $21.00 target price (down from $25.00) on shares of Oscar Health in a research report on Thursday, May 30th. Piper Sandler upped their price objective on Oscar Health from $25.00 to $28.00 and gave the stock an “overweight” rating in a report on Thursday, August 8th. Robert W. Baird began coverage on Oscar Health in a report on Thursday, May 30th. They set an “outperform” rating and a $28.00 price objective on the stock. Baird R W raised Oscar Health to a “strong-buy” rating in a research note on Thursday, May 30th. Finally, Wells Fargo & Company increased their price target on shares of Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a research report on Wednesday, June 12th. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $24.17.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. New York State Common Retirement Fund boosted its stake in shares of Oscar Health by 3.8% during the 4th quarter. New York State Common Retirement Fund now owns 64,856 shares of the company’s stock valued at $593,000 after purchasing an additional 2,394 shares in the last quarter. Victory Capital Management Inc. grew its holdings in shares of Oscar Health by 37.7% during the 4th quarter. Victory Capital Management Inc. now owns 18,852 shares of the company’s stock worth $172,000 after acquiring an additional 5,159 shares during the period. National Bank of Canada FI bought a new position in shares of Oscar Health in the 4th quarter worth approximately $1,071,000. Charles Schwab Investment Management Inc. lifted its stake in shares of Oscar Health by 3.1% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,160,483 shares of the company’s stock valued at $10,618,000 after purchasing an additional 35,128 shares during the period. Finally, Teacher Retirement System of Texas bought a new stake in shares of Oscar Health during the fourth quarter valued at approximately $406,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.